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Objective High-quality intensive care, including targeted temperature management (TTM) for 
patients with postcardiac arrest syndrome, is a key element for improving outcomes after out-
of-hospital cardiac arrest (OHCA). We aimed to assess the status of postcardiac arrest syndrome 
care, including TTM and 6-month survival with neurologically favorable outcomes, after adult 
OHCA patients were treated with TTM, using data from the Korean Hypothermia Network pro-
spective registry.
Methods We used the Korean Hypothermia Network prospective registry, a web-based multi-
center registry that includes data from 22 participating hospitals throughout the Republic of 
Korea. Adult comatose OHCA survivors treated with TTM between October 2015 and December 
2018 were included. The primary outcome was neurological outcome at 6 months.
Results Of the 1,354 registered OHCA survivors treated with TTM, 550 (40.6%) survived 6 months, 
and 413 (30.5%) had good neurological outcomes. We identified 839 (62.0%) patients with pre-
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INTRODUCTION
Despite recent advancements in critical care, out-of-hospital car-
diac arrest (OHCA) is still one of the major causes of death in many 
countries.1-3 High-quality intensive care, including targeted tem-
perature management (TTM) for patients with postcardiac arrest 
syndrome (PCAS), is a key element for improving outcomes after 
OHCA.1,4,5 TTM is known to improve survival and neurologic out-
comes after OHCA,6-9 and several other postcardiac arrest treat-
ment approaches such as emergency coronary angiography (CAG), 
hemodynamic optimization, ventilator management, and prog-
nostication may also impact patient outcomes.10-19
 Cardiac arrest etiology and quality of postcardiac arrest care, 
including TTM, as well as outcomes after OHCA differ between 
countries.20 It is therefore important to identify the current status 
of PCAS care in Korea in order to make recommendations that 
are suitable for the country’s specific circumstances. The Korean 
Hypothermia Network (KORHN) investigators previously published 
retrospective, multicenter, observational studies on postcardiac 
arrest care quality and outcomes in patients treated with TTM 
between January 2007 and December 2012.21 Since then, howev-
er, the guidelines have been updated, resulting in changes in TTM 
What is already known
High-quality intensive care, including targeted temperature management (TTM) for patients with postcardiac arrest 
syndrome, is a key element for improving outcomes after out-of-hospital cardiac arrest (OHCA). Several studies have 
reported the outcome and status of postcardiac arrest care, including TTM, in their own countries.
What is new in the current study
Of the 1,354 total out-of-hospital cardiac arrest survivors treated with TTM, 413(30.5%) had good neurologic out-
comes at 6 months. The most common target temperature and duration were 33°C and 24 hours. This is the first report 
from a large-scale multicentered prospective registry in Korea.
treatment, and the retrospective data at the time were based on 
limited research. The KORHN multicenter clinical research con-
sortium for TTM in South Korea, founded in 2010, therefore laun-
ched a multicenter, prospective registry of OHCA patients, and 
enrolled approximately 10,000 such patients from 22 participat-
ing institutions between October 2015 and December 2018. 
 Using this database, we aimed to assess the current status of 
PCAS care in Korea, including TTM and 6-month survival with neu-
rologically favorable outcomes, after adult OHCA patients were 
treated with TTM.
METHODS
Study design and participation
This study was a prospective, multicenter, observational cohort 
study. Data were collected from the KORHN prospective (KORHN-
PRO) registry, a web-based registry of OHCA patients treated with 
TTM that aimed to improve postcardiac arrest care quality and 
outcomes. Adult (≥18 years) comatose patients treated with TTM 
between October 2015 and December 2018 were included.
 Each investigator, from one of the 22 teaching hospitals that 
intended to be included in this registry, was required to fill out 
sumed cardiac etiology. A total of 937 (69.2%) collapses were witnessed, shockable rhythms 
were demonstrated in 482 (35.6%) patients, and 421 (31.1%) patients arrived at the emergency 
department with prehospital return of spontaneous circulation. The most common target tem-
perature was 33°C, and the most common target duration was 24 hours.
Conclusion The survival and good neurologic outcome rates of this prospective registry show 
great improvements compared with those of an earlier registry. While the optimal target tem-
perature and duration are still unknown, the most common target temperature was 33°C, and 
the most common target duration was 24 hours.
Keywords Out-of-hospital cardiac arrest; Hypothermia, induced; Registries; Critical care out-
comes
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the participation form available on the website of the KORHN-
PRO registry (http://pro.korhn.or.kr/). A registry manual was cre-
ated. Investigators were repeatedly educated every 3 months, and 
researchers were asked to share the queries and others that oc-
curred by attending the education every time. Five clinical re-
search associates monitored the data and improved their quality 
by sending queries to all investigators, and one data manager 
eventually examined the data and decided whether records could 
be accepted or needed revision.
 The participating institutions (n=22) were evenly distributed 
throughout the entire country (Fig. 1). The study design and plan, 
including the informed consent form, were approved by the insti-
tutional review boards of all participating hospitals and registered 
on the International Clinical Trials Registry Platform (NCT02827422). 
In accordance with national requirements and the principles of 
the Declaration of Helsinki, written informed consent was obtained 
from the patients’ legal surrogates rather than from the patients 
themselves.
Data collection
The KORHN-PRO registry collected a large amount of information, 
consisting of 136 variables with 839 datasets.
Baseline patient information
The date and place of cardiac arrest, hospital visit type (transferred 
or not), age, sex, height, weight, prearrest Glasgow-Pittsburgh Ce-
rebral Performance Category (CPC)/modified Rankin scale (mRS) 
score, and comorbidities (coronary heart disease, congestive heart 
failure, stroke, hypertension, diabetes mellitus, lung disease, renal 
impairment, liver cirrhosis, and malignancy) were documented.
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Resuscitation variables
Cardiac arrest etiology was dichotomized as medical or nonmedi-
cal; medical causes included cases in which the cardiac arrest was 
presumed to be of cardiac origin or due to other medical causes 
and those in which there was no obvious cause of cardiac arrest. 
The initial arrest rhythm was defined as a shockable rhythm when 
the first monitored rhythm was found to be ventricular fibrilla-
tion or pulseless ventricular tachycardia. Other resuscitation vari-
ables were as follows: witness of collapse, bystander cardiopulmo-
nary resuscitation (CPR), return of spontaneous circulation (ROSC) 
status (ROSC after hospital arrival, ROSC before hospital arrival, 
no ROSC), mechanical chest compression, epinephrine or vaso-
pressin dose, end tidal carbon dioxide concentration during resus-
citation, and time from collapse to ROSC.
TTM
The following TTM data of patients were prospectively collected: 
target temperature, target duration, temperature monitoring site, 
hourly body temperature from ROSC to 96 hours, TTM methods 
(blanket, ice bag, adhesive pad, garment, fan, linen, cold saline, 
intravascular catheter, lavage, and extracorporeal membrane oxy-
genation), time from ROSC to start of TTM, time from start of TTM 
to achieving the target temperature, maintenance duration, re-
warming duration, controlled normothermia, and duration and 
maximal temperature after rewarming for 3 days.
In-hospital data including treatments
Hemodynamic parameters, shock after ROSC (a systolic blood pres-
sure <90 mmHg for >30 minutes, or the need for supportive mea-
sures to maintain a blood pressure of 90 mmHg), the Glasgow 
Coma Scale score after ROSC, arterial blood gases, 12-lead elec-
trocardiography, and serum troponin levels were measured im-
mediately after ROSC. The lowest hypoxic index on the day, the 
cardiovascular sequential organ failure assessment score, serum 
creatinine levels, platelet counts, bilirubin levels, the patient’s flu-
id balance, and their neurologic status (i.e., their Glasgow Coma 
Scale score, pupillary light reflex, and corneal reflex) were evalu-
ated daily up to 7 days after ROSC. Adverse events within 7 days 
after ROSC (seizures, bleeding, infections, sepsis, pneumonia, hy-
pokalemia, hypophosphatemia, hypomagnesaemia, hypoglycemia 
[blood glucose <60 mg/dL], sustained hyperglycemia [blood glu-
cose >180 mg/dL for >4 hours], tachycardia [>130/min], and 
bradycardia [<40/min]) and rearrest events were documented. 
The registry contained data on advanced cardiac treatments (e.g., 
CAG, percutaneous coronary intervention, results of CAG, coro-
nary artery bypass graft, extracorporeal bypass, intra-aortic bal-
loon pump, use of thrombolytics, electrophysiology study, implant-
able cardioverter-defibrillator insertion, and pacemaker insertion), 
echocardiography, regional wall motion abnormalities, time from 
ROSC to CAG, and continuous renal replacement therapy.
Outcomes and outcome prediction modality
The researchers prospectively recorded whether there were any 
decisions regarding limitations of active treatments during hospi-
tal care (i.e., withdrawal of life sustaining therapy, whether pa-
tients underwent essential diagnostic testing, or whether do not 
attempt CPR orders were in place). Neurologic outcomes were in-
vestigated by the researchers at each hospital, and assessed at 
discharge as well as at 1 and 6 months after cardiac arrest. The 
KORHN protocol recommends a minimalist approach when as-
signing the Glasgow-Pittsburgh CPC score that is based on four 
simple questions, and the researchers contacted either surviving 
discharged patients or their relatives to calculate the score. Fol-
low-up was recommended by face-to-face or telephone interviews.
 The various modalities used for outcome prediction were also 
prospectively collected and included the following: brain com-
puted tomography (CT), brain magnetic resonance imaging, se-
rum neuron-specific enolase every 24 hours for 72 hours, median 
nerve somatosensory evoked potentials (SSEPs), and conventional 
electroencephalogram (EEG).
Primary outcome
The primary outcome was the neurologic outcome assessed using 
the CPC score 6 months after cardiac arrest according to the rec-
ommendations for outcome assessments in comatose cardiac ar-
rest survivors; it was recorded as CPC 1 (good performance), CPC 
2 (moderate disability), CPC 3 (severe disability), CPC 4 (vegetative 
state), or CPC 5 (brain death or death). Neurological outcomes 
were then dichotomized into good (CPC 1 or 2) or poor (CPC 3 to 
5).22,23 Additionally, we used the mRS to assess neurological out-
comes, with an mRS score of 0 to 3 being considered a good out-
come and an mRS score of 4 to 6 a poor outcome (with an mRS 
score of 6 indicating death).22,23
Statistical analysis
Categorical variables are presented as frequencies and percent-
ages. Comparisons of categorical variables were performed us-
ing chi square tests or Fisher’s exact test, as appropriate. We 
tested the distributions of continuous variables for normality 
using visual inspection and the Shapiro-Wilk test. Normally 
distributed data are expressed as means and standard deviations 
and assessed using Student’s t-test. Non-normally distributed 
data are expressed as medians and interquartile ranges and as-
sessed using the Mann-Whitney U-test. All data were analyzed 
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 RESULTS
Demographic and baseline characteristics
During the study period, a total of 10,258 patients with OHCA 
were initially screened for the registration. Of those, 1,373 pa-
tients were treated with TTM and thus included in the KORHN-
PRO registry. A total of 1,354 patients (98.6%) with complete 
data including the 6-month neurologic outcomes were finally in-
cluded in this study. 
 The patients’ clinical characteristics are shown in Table 1. A 
total of 961 patients (71.0%) were male, and the mean age was 
58 years. Patients with a good neurological outcome were signifi-
cantly more likely to be male and younger (P<0.001). Hyperten-
sion was the most frequent comorbidity. Patients with hyperten-
sion and diabetes mellitus were more likely to have a poor neuro-
logical outcome. There were 839 patients (62.0%) with presumed 
cardiac etiology. A total of 937 collapses (69.2%) were witnessed, 
and 834 patients (61.6%) received bystander CPR. Shockable 
rhythms were identified in 482 patients (35.6%), and 421 (31.1%) 
patients arrived at the ED with prehospital ROSC. Good neurolog-
ic outcomes were associated with witness of collapse, bystander 
CPR, shockable rhythms, shorter times from collapse to ROSC, and 
prehospital ROSC (P<0.001).
Clinical findings immediately after ROSC
Immediately after ROSC, 170 (12.6%) patients showed ST eleva-
tion on 12-lead electrocardiography (Table 2). Patients with a good 
Table 1. Demographic and resuscitation data of the patients
All  
(n=1,354)
Good at  
6 months 
(n=413)




Sex, male 961 (71.0) 322 (78.0) 639 (67.9) <0.001
Age (yr)  58.0±15.8  52.7±14.6  60.3±15.7 <0.001
Comorbidity 
   Healthy 408 (30.1) 171 (41.4) 237 (25.2) <0.001
   Coronary artery disease 269 (19.9) 95 (23.0) 174 (18.5) 0.055
   Hypertension 484 (35.7) 120 (29.1) 364 (38.7) 0.001
   Diabetes mellitus 328 (24.2) 64 (15.5) 264 (28.1) <0.001
   Cerebrovascular accident 64 (4.7) 17 (4.1) 47 (5.0) 0.483
Visit type 0.552
   Direct 943 (69.6) 283 (68.5) 660 (70.1)
   Transport 411 (30.4) 130 (31.5) 281 (29.9)
Resuscitation variables
   Cardiac etiology 839(62.0) 364 (88.1) 475 (50.5) <0.001
   Witnessed 937 (69.2) 347 (84.0) 590 (62.7) <0.001
   Bystander CPR 834 (61.6) 281 (68.0) 553 (58.8) 0.001
   Shockable rhythm 482 (35.6) 307 (74.3) 175 (18.6) <0.001
   Collapse to ROSC (min) 30 (18–43) 18 (13–26) 35 (24–47) <0.001
   Epinephrine (mg) 2.0 (0–4) 0.0 (0–1) 2.0 (1–4) <0.001
   Prehospital ROSC 421 (31.1) 283 (68.5) 138 (14.7) <0.001
Values are presented as number (%), mean±standard deviation, or median (in-
terquartile range).
CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation.
Table 2. Clinical findings immediately after return of spontaneous circulation
All  
(n=1,354)
Good at  
6 months (n=413)
Poor at  
6 months (n=941)
P-value
ST-elevation myocardial infarction 170 (12.6) 75 (18.2) 95 (10.1) <0.001
Neurologic examination
   GCS motor 302 (22.3) 201 (48.7) 101 (10.7) <0.001
   Pupillary light reflex 440 (32.5) 262 (63.4) 178 (18.9) <0.001
   Corneal reflex 268 (19.8) 178 (43.1) 90 (9.6) <0.001
Hemodynamic status
   Mean arterial pressure (mmHg) 92.2±31.5 100.9±30.8 88.2±30.9 <0.001
   Heart rate (beats/min) 105.5±29.2 103.0±29.3 106.6±29.0 0.043
   Temperature (°C) 35.7±1.3 35.9±1.0 35.6±1.4 0.001
   Pre-induction shock 695 (51.3) 140 (33.9) 555 (59.0) <0.001
Glucose (mg/dL) 254 (189–327) 238 (180–294) 266 (196–346) <0.001
Arterial blood gas analysis
   Hydrogen ion concentration 7.08 (6.92–7.23) 7.22 (7.09–7.30) 7.02 (6.89–7.17) <0.001
   PaCO2 (mmHg) 49.0 (36.1–71.7) 39.0 (32.0–48.2) 56.0 (39.2–79.4) <0.001
   PaO2 (mmHg) 110.0 (72.7–198.0) 108.8 (73.9–192.5) 110.0 (71.4–199.0) 0.649
   Bicarbonate (mmol/L) 15.0 (11.7–18.6) 15.7 (12.8–19.1) 14.6 (11.3–18.4) <0.001
Lactic acid (mmol/L) 9.7 (6.1–12.9) 7.0 (4.3–10.9) 10.6 (7.4–13.5) <0.001
Values are presented as number (%), mean±standard deviation, or median (interquartile range).
GCS, Glasgow Coma Scale; PaCO2, partial pressure of carbon dioxide in arterial blood; PaO2, partial pressure of oxygen in arterial blood. 
using IBM SPSS version 23.0 (IBM Corp., Armonk, NY, USA). 
Significance was set at P<0.05.
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neurologic outcome had a significantly higher mean arterial pres-
sure than patients with a poor neurologic outcome. Preinduction 
shock was more common in patients with a poor neurologic out-
come than in those with a good neurologic outcome (P<0.001). 
The poor neurologic outcome group had higher glucose and ele-
vated lactic acid levels than the good neurologic outcome group 
(P<0.001).
Neurological outcome and survival according to the first 
monitored rhythm
Fig. 2 shows an overview of the registered patients. Of the 1,354 
total patients, 550 (40.6%) survived 6 months, and 413 (30.5%) 
had good neurologic outcomes at 6 months. Of the 482 patients 
who experienced OHCA with shockable rhythms, 337 (69.9%) sur-
vived 6 months, and 307 (63.7%) had good neurologic outcomes 
at 6 months.
TTM practices and complications
The most common target temperature was 33°C, with an annual 
increase in the proportion of target temperatures above 35°C (Ta-
ble 3). The most common target duration was 24 hours, and most 
patients (89.7%) were actively rewarmed at a rate of 0.25°C/hr 
(54.8%). After rewarming, 736 patients (53.6%) maintained nor-
mothermia for an average of 32.6 hours. The hydrogel pad was 
most frequently (69%) used for induction, and 925 (67.4%) pa-
tients used it for maintenance and rewarming (Table 4).
 Table 5 shows incidences of complications during TTM. Seizures, 
bleeding, sepsis, hypoglycemia, sustained hyperglycemia, and re-
arrest were significantly more frequent in patients with poor neu-
rologic outcomes than in those with good neurologic outcomes.
Cardiac care and circulatory supportive therapy
Table 6 shows the use of cardiac care after ROSC. CAG was per-
formed in 497 patients (36.7%), and percutaneous coronary in-
tervention was performed in 206 patients (15.2%). CAG was per-










32 0 (0.0) 1 (0.2) 2 (0.4) 0 (0.0)
33 50 (82.0) 299 (71.4) 335 (74.6) 284 (66.8)
34 5 (8.2) 24 (5.7) 33 (7.3) 30 (7.1)
35 4 (6.6) 54 (12.9) 46 (10.2) 55 (12.9)
36 2 (3.3) 39 (9.3) 33 (7.3) 56 (13.2)
37 0 (0.0) 2 (0.5) 0 (0.0) 0 (0.0)
Target duration (hr)
12 2 (3.3) 2 (0.5) 0 (0.0) 0 (0.0)
24 58 (95.1) 409 (97.8) 444 (98.9) 416 (97.9)
36 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.2)
48 1 (1.6) 1 (0.2) 4 (0.9) 5 (1.2)
60 0 (0.0) 1 (0.2) 0 (0.0) 0 (0.0)
72 0 (0.0) 4 (1.0) 1 (0.2) 3 (0.7)
Values are presented as number (%).
Fig. 2. Survival and neurological outcomes at 6 months of the 1,354 patients with out-of-hospital cardiac arrest (OHCA) treated with targeted tempera-
ture management (TTM). Vf, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; CPC, Cerebral Performance Category.
1,354 OHCA treated with TTM  
482 Vf/pulseless VT
337 Survivor at 6 months  
(69.9%)
307 Good outcome at  
6 months  (63.7%)
 285 CPC 1
 22 CPC 2
 13 CPC 3
 17 CPC 4
 48 CPC 1
 11 CPC 2
 15 CPC 3
 32 CPC 4
 18 CPC 1
 7 CPC 2
 10 CPC 3
 45 CPC 4
 21 CPC 1
 1 CPC 2
 2 CPC 3
 3 CPC 4
59 Good outcome at  
6 months  (19.3%)
25 Good outcome at  
6 months  (4.9%)
22 Good outcome at  
6 months  (36.1%)
106 Survivor at 6 months  
(34.8%)
80 Survivor at 6 months  
(15.8%)
27 Survivor at 6 months  
(44.3%)
305 PEA 506 Asystole 61 Unknown
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formed in 349 (72.4%) of 482 patients with shockable rhythms 
and in 145 (85.3%) of 170 patients with ST-elevation myocardial 
infarction. The median time from ROSC to CAG was 2.7 hours, 
and 378 (76.1%) patients underwent CAG within 24 hours.
Modalities for outcome prediction
Neurologic examinations 72 hours after ROSC were performed in 
1,181 (87.2%) patients, and serum neuron-specific enolase was 
checked in 815 (59.4%) patients. SSEP was performed in 339 and 
EEG in 700 patients. Most patients (92.5%) underwent brain CT 
examinations, and the median time to exam was 1.5 hours. A to-
tal of 655 patients underwent brain magnetic resonance imaging 
examinations, and the median time to exam was 78 hours for 
predicting neurologic outcome after OHCA (Table 7).
DISCUSSION
The KORHN committee launched a multicenter, prospective regis-
try that focuses on OHCA patients treated with TTM since Octo-
ber 2015. This report briefly describes the characteristics and out-
comes of the registry from October 2015 to December 2018. Of 
the 1,354 registered OHCA survivors treated with TTM, 550 
(40.6%) survived 6 months, and 413 (30.5%) had good neurologi-
cal outcomes.
 This study has several strengths. First, this is the first prospec-
tive registry involving multiple centers in Korea. Second, 98.6% of 
all enrolled patients provided data on the primary outcome of our 
study, that is, neurologic outcome at 6 months after cardiac ar-
rest.
 The good neurologic outcome rate of all patients was 30.5%, 
and the good neurologic outcome rate of patients with initial shock-
able rhythms was 63.7%. In an earlier TTM trial, 46% of patients 
with good neurologic outcomes were in the 33°C group and 48% 
in the 36°C group.8 However, as this earlier trial did not report 
rates of good neurologic outcome at 6 months according to ini-
tial rhythm, no direct comparison with our registry is possible. In 
a recently published Time-differentiated therapeutic hypothermia 
(TTH) 48 trial, the rate of good neurologic outcomes at 6 months 
was 64% in the 24-hour group and 69% in the 48-hour group.24 
Table 5. Complications during targeted temperature management
All  
(n=1,354)
Good at  
6 months 
(n=413)




Seizure 322 (23.8) 58 (14.0) 264 (28.1) <0.001
Bleeding 65 (4.8) 8 (1.9) 57 (6.1) 0.001
Infection 675 (49.9) 196 (47.5) 479 (50.9) 0.243
   Pneumonia 519 (38.3) 175 (42.4) 344 (36.6) 0.043
   Sepsis 157 (11.6) 20 (4.8) 137 (14.6) <0.001
Hypokalemia 443 (32.7) 128 (31.0) 315 (33.5) 0.370
Hypoglycemia 152 (11.2) 25 (6.1) 127 (13.5) <0.001
Sustained hyperglycemia 697 (51.5) 127 (30.8) 570 (60.6) <0.001
Tachycardia 273 (20.2) 89 (21.5) 184 (19.6) 0.399
Bradycardia 96 (7.1) 35 (8.5) 61 (6.5) 0.189
Re-arrest 260 (19.2) 31 (7.5) 229 (24.3) <0.001
Values are presented as number (%).
Table 4. Targeted temperature management methods
Technique Induction
 Maintenance to end 
of rewarming
Feedback device 
   Hydrogel pad 947 (69.0) 925 (67.4)
   Blanket or garment 284 (20.7) 268 (19.5)
   Endovascular 136 (9.9) 131 (9.5)
Ice pack 130 (9.5) 19 (1.4)
Cold saline 120 (8.7) 5 (0.4)
Cold gastric lavage 2 (0.1) 0
Cold bladder irrigation 85 (6.2) 6 (0.4)
Extracorporeal cooling 15 (1.1) 15 (1.1)
Values are presented as number (%).







Extracorporeal cardiopulmonary  
resuscitation
15 (1.1) 10 (2.1) 6 (3.5)
Extracorporeal membrane oxygenation 49 (3.6) 29 (6.0) 20 (11.8)
Intraaortic balloon pump 9 (0.7) 5 (1.0) 3 (1.8)
Coronary angiography 497 (36.7) 349 (72.4) 145 (85.3)
   Percutaneous coronary intervention 206 (15.2) 156 (32.4) 102 (60.0)
   Time to coronary angiography (hr) 2.7 (2–21) 2.9 (2–79) 2.0 (1.0–3.0)
   Early coronary angiography 378 (27.9) 248 (51.5) 130 (76.5)
Implantable cardioverter defibrillator 96 (7.1) 90 (18.7) 11 (6.5)
Echocardiogram 723 (53.4) 364 (75.5) 129 (75.9)
   Regional wall motion abnormality 254 (18.8) 154 (32.0) 81 (47.6)
Values are presented as number (%) or median (interquartile range).
STEMI, ST-elevation myocardial infarction.
Table 7. Modalities for outcome prediction (n=1,354)
Modality Value
Neurological exam at 72 hours 1,181 (87.2)
Neuron-specific enolase 815 (59.4)
Electroencephalography 700 (51.8)
Somatosensory evoked potential 339 (25.0)
Brain computed tomography 1,252 (92.5)
   Time to exam (hr) 1.5 (1.0–2.6)
Brain magnetic resonance imaging 655 (48.6)
   Time to exam (hr) 78 (70–91)
Values are presented as number (%) or median (interquartile range).
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This means that, in the current study, the proportion of patients 
with an initial shockable rhythm was lower than the same pro-
portion reported in earlier European trials, such as the just men-
tioned TTM and TTH 48 trials; however, our good outcome rate is 
similar to those of earlier reports.
 In our prospective registry, the most common target tempera-
ture was 33°C, and the most common target duration was 24 
hours. Although the optimal target temperature and duration are 
still unknown, many guidelines recommend a target temperature 
of 32°C to 36°C and a minimum target duration of 24 hours.1,5 In 
the United States, the rate of TTM applications has decreased by 
more than 6% since the publication of the TTM trial.24 The Aus-
tralian and New Zealand Intensive Care Society reported that the 
lowest average temperature of PCAS patients in the first 24 hours 
in the ICU rose after publication of the TTM trial, and that this 
change was associated with an increased frequency of fever and 
a tendency toward an increase in mortality.25 In the Korean pro-
spective registry, although a target temperature of 33°C was the 
most common, the proportion of target temperatures of 33°C has 
been decreasing over the years. However, the current study did 
not reveal a relationship between the change in target tempera-
ture and outcomes. Further research is needed to expand on these 
findings. 
 CAG was performed in 497 patients (36.7%), and emergency 
CAG, which was defined as CAG performed within 24 hours after 
ROSC, was performed in 378 patients (27.9%). The median time 
from ROSC to CAG was 2.7 hours, and 378 (76.1%) patients un-
derwent CAG within 24 hours. The TTH 48 trial reported that emer-
gency CAG was performed in 82.6% of patients.24 Although there 
was a difference in the initial shockable rhythm rates between 
the TTH 48 trial and the KORHN-PRO registry, our study shows 
that even for ST-elevation myocardial infarction cases, the emer-
gency CAG rate was 76.5%; there is thus room for improvement 
in PCAS care. Additionally, it will be necessary to study the effect 
of emergency CAG on the Korean population.
 Brain CT was the most frequently used modality (92.5%) for 
outcome prediction and SSEP the least frequently performed, at a 
rate of 25%. According to one survey from the European Society 
of Intensive Care Medicine, EEG is the most common tool in rou-
tine clinical practice, with intermittent EEG, brain CT, and SSEP 
being considered the most useful tools for assessing prognosis 
after cardiac arrest.26 Future studies using the KORHN-PRO regis-
try data will reveal the associations between outcome predictors 
and prognosis after cardiac arrest.
 Our study has several limitations. First, the KORHN-PRO regis-
try included only patients with OHCA who were treated with TTM. 
Therefore, we were not able to assess the ratio of TTM applica-
tions, the total OHCA survival rate, or the effectiveness of TTM. 
Second, some missing data in the KORHN-PRO registry, in spite 
of the data manager and clinical research associates monitoring 
the data and giving feedback to the researchers, might have af-
fected the results. Third, most of the included facilities are teach-
ing or university-affiliated hospitals located within the nation’s 
capital region. Therefore, a selection bias could not be avoided.
 In summary, of the 1,354 OHCA survivors treated with TTM, 
550 (40.6%) survived 6 months, and 413 (30.5%) had good neu-
rologic outcomes at 6 months. The most common target temper-
ature was 33°C, and the most common target duration was 24 
hours. CAG was performed in 497 patients (36.7%), and emer-
gency CAG, which was defined as CAG performed within 24 hours 
after ROSC, was performed in 378 patients (27.9%).
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